A. Koitka

发表

Wavelet de-noising of laser Doppler reactive hyperemia signals to diagnose peripheral arterial occlusive diseases

Anne Humeau-Heurtier, Jean-Pierre L'Huillier, Jean-Louis Saumet, 2002, IEEE Transactions on Biomedical Engineering.

Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2010, Circulation research.

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2008, Diabetes.

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy

C. Tikellis, A. Koitka, 2008, TheScientificWorldJournal.

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor

Merlin C. Thomas, T. Walther, M. Cooper, 2010, Diabetologia.

Absence of RAGE protects from atherosclerosis in diabetes RAGE DEFICIENCY ATTENUATES THE DEVELOPMENT OF ATHEROSCLEROSIS IN DIABETES

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2008 .

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

M. Cooper, A. Calkin, A. Soro-Paavonen, 2011, Diabetologia.

ANGIOTENSIN CONVERTING ENZYME 2 IN THE KIDNEY

C. Tikellis, A. Koitka, M. Cooper, 2008, Clinical and experimental pharmacology & physiology.

Eplerenone does not attenuate diabetes-associated atherosclerosis

M. Cooper, A. Koitka, T. Allen, 2009, Journal of hypertension.

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

T. Walther, M. Cooper, K. Sourris, 2010, Diabetologia.

Eplerenone does not attenuate diabetes-associated atherosclerosis

A. Koitka, T. Allen, P. Koh, 2009, Journal of hypertension.